Fingerprint
Dive into the research topics where Alice Mims is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 3 Finished
-
Pharmacodynamically directed targeted therapy for leukemia
Byrd, J. C. (PI), Mims, A. (CoPI), Coss, C. (CoPI) & Hertlein, E. (CoPI)
05/1/25 → 04/30/26
Project: Research
-
Understanding Treatment Response Patterns And Therapy Resistance In IDH-Mutant AML
Eisfeld, A.-K. (PI), Mims, A. (CoPI) & Mardis, E. (CoPI)
07/1/22 → 06/30/25
Project: Research
-
Targeting NAMPT in Acute Myeloid Leukemia
Lapalombella, R. (PI), Mims, A. (CoPI) & Sampath, D. (CoPI)
08/2/18 → 07/31/23
Project: Research
-
Clinical outcomes of older patients with NPM1-mutated or KMT2A-rearranged AML before menin inhibitors: a Beat AML report
Zeidner, J. F., Jain, J., Welkie, R. L., Huang, Y., Swords, R. T., Traer, E., Stein, E. M., Lin, T. L., Madanat, Y. F., Collins, R. H., Baer, M. R., Duong, V. H., Blum, W. G., Arellano, M. L., Stock, W., Odenike, O., Olin, R. L., Smith, C. C., Foran, J. M. & Schiller, G. J. & 15 others, , Apr 14 2026, In: Blood Advances. 10, 7, p. 2328-2332 5 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Concomitant or sequential lower intensity triplet therapy in AML
Senapati, J., Daver, N. G., Jain, J. & Mims, A. S., Apr 2026, In: The Lancet Haematology. 13, 4, p. e197-e198Research output: Contribution to journal › Comment/debate
-
Enhancing tyrosine kinase inhibitor sensitivity by restoring IKAROS activity on GLUT1 expression and glycolysis in Philadelphia chromosome-positive acute lymphoblastic leukemia
Zhang, L., Han, Q., Xiang, H., Lapalombella, R., Eisfeld, A. K., Hanel, W. G., Brammer, J. E., Mims, A. S., Woyach, J. A., Song, C. & Ge, Z., Apr 2026, In: Leukemia. 40, 4, p. 794-805 12 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Pharmacologic Targeting of miR29b with Bortezomib and Sorafenib to Improve Decitabine Sensitivity in Patients with Acute Myeloid Leukemia: Results from a Phase 1 Dose-Escalation Trial
Handa, S., Koenig, K., Zhao, Q., Mims, A. S., Vasu, S., Garzon, R., Haque, T., Benson, D. M., Klisovic, R. B., Marcucci, G., Walker, A. R. & Bhatnagar, B., Jan 2026, In: Cancers. 18, 1, 45.Research output: Contribution to journal › Article › peer-review
Open Access -
Predictors of complete molecular response and impact of allogeneic hematopoietic stem cell transplantation on outcome in patients with Philadelphia chromosome positive acute lymphoblastic leukemia (ALL): results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)
Mohty, R., Narra, R., Mims, A. S., Hunter, C., Shallis, R. M., Kota, V., Jamy, O., Coltoff, A., Othman, T. A., Jonas, B. A., Patel, A. A., DuVall, A. S., Foucar, C. E., Abdelsamia, M., Palmisiano, N., Patel, S. A., Curran, E., Omer, Z., Advani, A. & Atallah, E. & 2 others, , 2026, (Accepted/In press) In: Leukemia and Lymphoma.Research output: Contribution to journal › Article › peer-review